In 2024, Sabiedrība ar ierobežotu atbildību "NORTHERN SYNTHESIS" had revenue of 1.6 million EUR and profit of 115.5 thousand EUR. The company has 44 employees. Beneficial owners: Ēriks Masteiko.
| year | 2024Latest | 2023 | 2022 |
|---|---|---|---|
Revenue | 1,6m € -35.4% | 2,5m € +12.3% | 2,2m € +8.8% |
Profit | 115,5k € -48.8% | 225,6k € +117.8% | 103,6k € -13.5% |
Assets | 3,2m € -0.2% | 3,2m € -0.8% | 3,3m € +12.7% |
Liabilities | 1,7m € -6.6% | 1,8m € -12.1% | 2,1m € +14.5% |
Equity | 1,5m € +8.2% | 1,4m € +19.2% | 1,2m € +9.7% |
Employees | 47 -7.8% | 51 -7.3% | 55 +7.8% |
Overall rating | A87/100 |
Financial health | 95/100 |
Credit history | 100/100 |
Legal history | 100/100 |
Business activity | 35/100 |
| Overall risk | Low |
No risk flags | |
No tax debts | |
Positive profit | |
Regular report filing | |
| Name, surname | Birth date | Position | Representation rights | Registered | |
|---|---|---|---|---|---|
| Board member | Independently |
| Name | Changed |
|---|---|
| SIA "NORTHERN SYNTHESIS" | 1 November 2016 |
| "MEDPRO INC." SIA | 4 March 2016 |
| Sabiedrība ar ierobežotu atbildību "MEDPRO INC." | 29 September 2016 |
| Sabiedrība ar ierobežotu atbildību "MEDPRO INC." | 10 August 2004 |
| SIA "NORTHERN SYNTHESIS" | 1 November 2016 |
| "MEDPRO INC." SIA | 4 March 2016 |
| Sabiedrība ar ierobežotu atbildību "MEDPRO INC." | 29 September 2016 |
| Sabiedrība ar ierobežotu atbildību "MEDPRO INC." | 10 August 2004 |
| SIA "NORTHERN SYNTHESIS" | 1 November 2016 |
| "MEDPRO INC." SIA | 4 March 2016 |
| Sabiedrība ar ierobežotu atbildību "MEDPRO INC." | 29 September 2016 |
| Sabiedrība ar ierobežotu atbildību "MEDPRO INC." | 10 August 2004 |
| SIA "NORTHERN SYNTHESIS" | 1 November 2016 |
| "MEDPRO INC." SIA | 4 March 2016 |
| Sabiedrība ar ierobežotu atbildību "MEDPRO INC." | 29 September 2016 |
| Sabiedrība ar ierobežotu atbildību "MEDPRO INC." | 10 August 2004 |
| SIA "NORTHERN SYNTHESIS" | 1 November 2016 |
| "MEDPRO INC." SIA | 4 March 2016 |
| Sabiedrība ar ierobežotu atbildību "MEDPRO INC." | 29 September 2016 |
| Sabiedrība ar ierobežotu atbildību "MEDPRO INC." | 10 August 2004 |
Project count
45
Total funding
€127 630 210
EU support
€53 621 604
| Project | Period | Role | Funding received | Status |
|---|---|---|---|---|
Atbalsts pētniecībai un internacionalizācijai Farmācijas, biomedicīnas un medicīnas tehnoloģiju kompetences centra ietvaros 5.1.1.2.i.0/2/24/A/CFLA/005 Program: AF | 2024. gada 2. jūlijs until 2027. gada 31. decembris | partner | - | Līgums |
Atbalsts pētniecībai un internacionalizācijai Farmācijas, biomedicīnas un medicīnas tehnoloģiju kompetences centra ietvaros 5.1.1.2.i.0/2/24/A/CFLA/005 Program: AF | 2024. gada 2. jūlijs until 2027. gada 31. decembris | partner | - | Līgums |
Atbalsts pētniecībai un internacionalizācijai Farmācijas, biomedicīnas un medicīnas tehnoloģiju kompetences centra ietvaros 5.1.1.2.i.0/2/24/A/CFLA/005 Program: AF | 2024. gada 2. jūlijs until 2027. gada 31. decembris | partner | - | Līgums |
Atbalsts pētniecībai un internacionalizācijai Farmācijas, biomedicīnas un medicīnas tehnoloģiju kompetences centra ietvaros 5.1.1.2.i.0/2/24/A/CFLA/005 Program: AF | 2024. gada 2. jūlijs until 2027. gada 31. decembris | partner | - | Līgums |
Atbalsts pētniecībai un internacionalizācijai Farmācijas, biomedicīnas un medicīnas tehnoloģiju kompetences centra ietvaros 5.1.1.2.i.0/2/24/A/CFLA/005 Program: AF | 2024. gada 2. jūlijs until 2027. gada 31. decembris | partner | - | Līgums |
Atbalsts pētniecībai un internacionalizācijai Farmācijas, biomedicīnas un medicīnas tehnoloģiju kompetences centra ietvaros 5.1.1.2.i.0/2/24/A/CFLA/005 Program: AF | 2024. gada 2. jūlijs until 2027. gada 31. decembris | partner | - | Līgums |
Atbalsts pētniecībai un internacionalizācijai Farmācijas, biomedicīnas un medicīnas tehnoloģiju kompetences centra ietvaros 5.1.1.2.i.0/2/24/A/CFLA/005 Program: AF | 2024. gada 2. jūlijs until 2027. gada 31. decembris | partner | - | Līgums |
Atbalsts pētniecībai un internacionalizācijai Farmācijas, biomedicīnas un medicīnas tehnoloģiju kompetences centra ietvaros 5.1.1.2.i.0/2/24/A/CFLA/005 Program: AF | 2024. gada 2. jūlijs until 2027. gada 31. decembris | partner | - | Līgums |
Atbalsts pētniecībai un internacionalizācijai Farmācijas, biomedicīnas un medicīnas tehnoloģiju kompetences centra ietvaros 5.1.1.2.i.0/2/24/A/CFLA/005 Program: AF | 2024. gada 2. jūlijs until 2027. gada 31. decembris | partner | - | Līgums |
5.1.1.2.i.0/2/24/A/CFLA/005 | - | partner | - | - |
5.1.1.2.i.0/2/24/A/CFLA/005 | - | partner | - | - |
5.1.1.2.i.0/2/24/A/CFLA/005 | - | partner | - | - |
5.1.1.2.i.0/2/24/A/CFLA/005 | - | partner | - | - |
5.1.1.2.i.0/2/24/A/CFLA/005 | - | partner | - | - |
5.1.1.2.i.0/2/24/A/CFLA/005 | - | partner | - | - |
5.1.1.2.i.0/2/24/A/CFLA/005 | - | partner | - | - |
5.1.1.2.i.0/2/24/A/CFLA/005 | - | partner | - | - |
5.1.1.2.i.0/2/24/A/CFLA/005 | - | partner | - | - |
5.1.1.2.i.0/2/24/A/CFLA/005 | - | partner | - | - |
5.1.1.2.i.0/2/24/A/CFLA/005 | - | partner | - | - |
5.1.1.2.i.0/2/24/A/CFLA/005 | - | partner | - | - |
5.1.1.2.i.0/2/24/A/CFLA/005 | - | partner | - | - |
5.1.1.2.i.0/2/24/A/CFLA/005 | - | partner | - | - |
5.1.1.2.i.0/2/24/A/CFLA/005 | - | partner | - | - |
5.1.1.2.i.0/2/24/A/CFLA/005 | - | partner | - | - |
5.1.1.2.i.0/2/24/A/CFLA/005 | - | partner | - | - |
5.1.1.2.i.0/2/24/A/CFLA/005 | - | partner | - | - |
5.1.1.2.i.0/2/24/A/CFLA/005 | - | partner | - | - |
5.1.1.2.i.0/2/24/A/CFLA/005 | - | partner | - | - |
5.1.1.2.i.0/2/24/A/CFLA/005 | - | partner | - | - |
5.1.1.2.i.0/2/24/A/CFLA/005 | - | partner | - | - |
5.1.1.2.i.0/2/24/A/CFLA/005 | - | partner | - | - |
5.1.1.2.i.0/2/24/A/CFLA/005 | - | partner | - | - |
5.1.1.2.i.0/2/24/A/CFLA/005 | - | partner | - | - |
5.1.1.2.i.0/2/24/A/CFLA/005 | - | partner | - | - |
5.1.1.2.i.0/2/24/A/CFLA/005 | - | partner | - | - |
5.1.1.2.i.0/2/24/A/CFLA/005 | - | partner | - | - |
5.1.1.2.i.0/2/24/A/CFLA/005 | - | partner | - | - |
5.1.1.2.i.0/2/24/A/CFLA/005 | - | partner | - | - |
5.1.1.2.i.0/2/24/A/CFLA/005 | - | partner | - | - |
5.1.1.2.i.0/2/24/A/CFLA/005 | - | partner | - | - |
5.1.1.2.i.0/2/24/A/CFLA/005 | - | partner | - | - |
5.1.1.2.i.0/2/24/A/CFLA/005 | - | partner | - | - |
5.1.1.2.i.0/2/24/A/CFLA/005 | - | partner | - | - |
5.1.1.2.i.0/2/24/A/CFLA/005 | - | partner | - | - |
Sabiedrība ar ierobežotu atbildību "NORTHERN SYNTHESIS" is located at Rīga, Ģertrūdes iela 15/17, LV-1011.
In 2024, Sabiedrība ar ierobežotu atbildību "NORTHERN SYNTHESIS" had revenue of 1 617 845 EUR and profit of 115 486 EUR. Compared to previous year, revenue decreased by 35.4%. View full financial report →
In 2024, Sabiedrība ar ierobežotu atbildību "NORTHERN SYNTHESIS" had an average of 44 employees. View tax history →
The beneficial owners of Sabiedrība ar ierobežotu atbildību "NORTHERN SYNTHESIS" are Ēriks Masteiko. View ownership details →
Yes, Sabiedrība ar ierobežotu atbildību "NORTHERN SYNTHESIS" is registered as an active VAT payer with VAT number LV40003264804.
In 2024, the average gross salary at Sabiedrība ar ierobežotu atbildību "NORTHERN SYNTHESIS" was approximately 1263,87 € per month (net ~ 972,76 €). This is an approximate calculation. View salary details →
Sabiedrība ar ierobežotu atbildību "NORTHERN SYNTHESIS" was founded on September 5, 1995. The company has been operating for 31 years.
| Indicator | Value | Rank | Comparison | |
|---|---|---|---|---|
Company age | 31 years | 4 - 8 | 64% | |
Net revenue | 1 617 845,00 € | 3 - 7 | 67% | |
Profit | 115 486,00 € | 3 - 7 | 71% | |
Equity | 1 517 143,00 € | 2 - 6 | 70% | |
Assets | 3 240 019,00 € | 2 - 6 | 79% | |
Fixed assets | 1 044 764,00 € | - | 90% | |
Investments | 2977,00 € | - | 10% | |
Liquidity | 2.79 | - | 75% | |
Profitability | 7.1% | - | 10% | |
Registered capital | 153 612,00 € | - | 60% |
Annual financial report for 2024.
Annual financial report for 2023.
Annual financial report for 2022.
Annual financial report for 2021.
Annual financial report for 2020.
Annual financial report for 2019.
Registered in the Latvian company register.
| Name, surname | Shares | Ownership rights | |
|---|---|---|---|
| Sabiedrība ar ierobežotu atbildību "ExMed" | 153 612 | 100.00% |
| Name, surname | Nationality | Birth date | |
|---|---|---|---|
| Ēriks Masteiko | LV |